FindTrial
Sign In

Phase III Clinical Study of Intraveous S-021812 in Patients with Influenza Virus Infection - Assessments in Patients with High-Risk Factors -

Phase III Clinical Study of Intraveous S-021812 in Patients with Influenza Virus Infection - Assessments in Patients with High-Risk Factors -

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080220737
Enrollment
Unknown
Registered
2009-05-27
Start date
2009-05-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

influenza virus infection

Interventions

investigational material(s) Generic name etc : S-021812 (Peramivir) INN of investigational material : Therapeutic category code : 629 Other chemotherapeutics Dosage and Administration for Investigati

Sponsors

SHIONOGI & CO., LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients with high-risk factors, who diagnosed with influenza virus infection.

Exclusion criteria

Exclusion criteria:

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026